Trial Profile
A retrospective cohort, multicentre study evaluating efficacy of Raltegravir based therapy in treatment experienced patients with HIV-1 infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Feb 2017
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 13 Feb 2017 New trial record
- 25 Jan 2017 Results published in the Drugs in R and D